Collaborators

Ballard Lab collaboration description.

Photo credit: Mallinckrodt Institute of Radiology

We study disease-relevant cell and organ signaling pathways in inflammatory bowel disease (IBD, which includes Crohn’s disease and ulcerative colitis) using molecular and cell biology, multi-omics technologies (e.g., single-cell and spatial transcriptomics, proteomics, whole-genome/exome sequencing, metagenomics), murine models, and human tissues.

Photo Credit: Cao Lab Website

Study of cellular and molecular mechanisms by which gut mycobiota (fungi) modulates local and systemic health with a goal to develop better biomarkers and therapeutic approaches.

Photo Credit: Matt Miller/WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

In the Imaging Informatics for Interventions (INVent) Laboratory, we develop artificial intelligence (AI) schemes to assist the clinician toward enabling precision medicine by “unlocking” embedded information captured by different data modalities, in an intuitive and generalizable fashion.

Photo Credit: INVent Lab website

In the last decade therapeutic strategies have evolved to utilize living cells as a means to treat human disease. These therapies include the engineering of immune cells, stem cells and bacteria to selectively target mechanisms that underlie cancer, immune and metabolic diseases. The Cohen Laboratory focuses on the development of these novel therapies and their application to human diseases.